StockStory flags Lucid and 10x Genomics as sells, iRhythm as a watchlist pick

Industry
โดย StockStory·Read original
Summary · why it matters

StockStory highlights one unprofitable stock to watch and two to avoid. Lucid Group, with a trailing 12-month GAAP operating margin of negative 271%, is flagged for its negative 136% gross margin and cash-burning history that raises dilution risk. 10x Genomics, at a negative 6.1% operating margin, is cited for sluggish 1.1% annual revenue growth and negative returns on capital. iRhythm Technologies, with a negative 5.2% operating margin, earns a watchlist spot due to 23.9% annual revenue growth and a positive free cash flow profile.

Impact on stocks 3

Biotech & Genomic Medicine± Mixed · 2 stocks
iRhythm Technologies Inc
IRTC
▲ PositiveCapitalrelevance

StockStory flags iRhythm as a watchlist pick due to strong revenue growth and positive free cash flow.

10X Genomics Inc
TXG
▼ NegativeCapitalrelevance

StockStory flags 10x Genomics as a sell due to sluggish revenue growth and negative returns on capital.

Electrification & Mobility▼ · 1 stocks
Lucid Group Inc
LCID
▼ NegativeCapitalrelevance

StockStory flags Lucid as a sell due to deeply negative margins and cash burn raising dilution risk.

© 2026 MarketDXNews